샘플 요청 목록

 카트 문의
시장보고서
상품코드
1779886

중증 하지허혈 치료 시장

Critical Limb Ischemia Treatment
발행일: | 리서치사: Market Glass, Inc. (Formerly Global Industry Analysts, Inc.) | 페이지 정보: 영문 375 Pages | 배송안내 : 1-2일 (영업일 기준)

    
    
    



※ 본 상품은 영문 자료로 한글과 영문 목차에 불일치하는 내용이 있을 경우 영문을 우선합니다. 정확한 검토를 위해 영문 목차를 참고해주시기 바랍니다.

세계의 중증 하지허혈 치료 시장은 2030년까지 81억 달러에 달할 전망

2024년에 56억 달러로 추정되는 세계의 중증 하지허혈 치료 시장은 2024-2030년에 CAGR 6.5%로 성장하며, 2030년에는 81억 달러에 달할 것으로 예측됩니다. 이 리포트에서 분석한 부문의 하나인 창상관리용 드레싱은 CAGR 4.8%를 기록하며, 분석 기간 종료시에는 28억 달러에 달할 것으로 예상됩니다. 생물제제 부문의 성장률은 분석 기간 중 CAGR 8.2%로 추정됩니다.

미국 시장은 15억 달러로 추정, 중국은 CAGR 9.8%로 성장 예측

미국의 중증 하지허혈 치료 시장은 2024년에 15억 달러로 추정됩니다. 세계 2위의 경제대국인 중국은 2030년까지 16억 달러의 시장 규모에 달할 것으로 예측되며, 분석 기간인 2024-2030년의 CAGR은 9.8%입니다. 기타 주목할 만한 지역별 시장으로는 일본과 캐나다가 있으며, 분석 기간 중 CAGR은 각각 3.3%와 6.2%로 예측됩니다. 유럽에서는 독일이 CAGR 4.2%로 성장할 것으로 예측됩니다.

세계 중증 허혈성 사지 치료 시장 - 주요 동향 및 촉진요인 정리

중증 허혈성 사지 치료에 대한 수요가 증가하는 이유는 무엇인가? 말초동맥질환 환자 증가에 대한 이해

세계 중증 허혈성 하지(CLI) 치료 시장은 말초동맥질환(PAD), 당뇨병, 심혈관질환의 유병률 증가로 인해 빠르게 성장하고 있습니다. CLI는 PAD의 중증형이며, 하지의 혈류 감소를 초래하고 종종 치유되지 않는 궤양, 괴저, 절단 위험을 초래합니다. 전 세계에서 만성질환의 부담이 증가함에 따라 의료 서비스 프로바이더와 제약 회사는 환자의 예후를 개선하기 위해 첨단 치료 옵션에 주목하고 있습니다. 인구 고령화, 생활습관 관련 위험요인, 비만 증가 등으로 인해 효과적인 CLI 치료에 대한 수요가 더욱 증가하고 있습니다. 또한 저침습적 혈관내 치료와 재생의료의 발전은 CLI 환자들에게 새로운 희망을 가져다주고 있습니다.

중증 허혈성 사지의 주요 치료법은? 주요 부문 살펴보기

CLI 치료 시장은 혈행재건술, 약리학적 중재, 신흥 재생요법 등 다양한 치료 접근법으로 구성되어 있습니다. 혈관성형술이나 스텐트 삽입술과 같은 혈관내 치료는 CLI 환자의 혈류 회복을 위한 표준 치료법이며, 새로운 약물 코팅 풍선 기술은 장기적인 효과를 높이고 있습니다. 우회술과 같은 외과적 치료도 중증 환자에게 널리 사용되고 있습니다. 항혈소판 요법과 항응고 요법을 포함한 약물 치료는 질병의 진행을 예방하는 데 중요한 역할을 합니다. 또한 줄기세포 치료나 유전자 기반 치료와 같은 재생의료 접근법은 혈관 재생과 상처 치유를 촉진하는 데 유망 결과를 보여주고 있습니다. 원격의료와 AI 진단의 통합은 조기발견과 맞춤형 치료 전략을 더욱 향상시키고 있습니다.

기술이 CLI 치료를 어떻게 변화시킬 것인가: AI, 바이오소재, 맞춤형 의료의 역할

CLI 치료 분야는 바이오소재, AI 기반 진단, 정밀의료의 기술 혁신으로 진화하고 있습니다. AI가 탑재된 영상 진단 툴은 혈관 건강 상태를 분석하고 허혈 부위를 보다 정확하게 파악하여 조기 발견을 강화합니다. 생체공학에 의한 인공혈관 및 조직 스캐폴더의 개발로 혈류 회복이 장기간 지속되어 치료 성적이 향상되고 있습니다. 또한 유전자 치료와 줄기세포 이식의 발전은 절단의 필요성을 줄일 수 있는 잠재적인 재생 솔루션을 제공합니다. 웨어러블 건강 모니터링 장치도 혈액 순환을 추적하고 실시간 환자 관리를 가능하게 하는 역할을 하고 있습니다. 맞춤형 의료가 확산됨에 따라 유전자 및 대사 프로파일에 기반한 맞춤형 치료 전략이 CLI의 치료 효과를 향상시키고 있습니다.

CLI 치료 시장의 성장 원동력은? 주요 시장 영향요인

중증 허혈성 사지 치료 시장의 성장을 주도하는 요인으로는 질병 유병률 증가, 의료비 지출 증가, 혈관내 치료 및 재생 치료의 발전 등이 있습니다. 혈관 수술 및 중재적 심장학 프로그램의 확대로 첨단 CLI 치료에 대한 접근성이 향상되고 있습니다. 또한 조기 검진 및 PAD에 대한 인지도를 높이기 위한 정부의 구상이 진단율 향상에 기여하고 있습니다. 가치 기반 의료 모델의 부상으로 비용 효율적인 CLI 치료법 개발이 촉진되고 있으며, 충분한 서비스를 받지 못하는 사람들에게도 치료가 더 쉽게 다가갈 수 있게 되었습니다. 새로운 혈관 재생 기술의 지속적인 연구와 세계 헬스케어 인프라의 확장으로 CLI 치료 시장은 큰 발전과 장기적인 성장을 이룰 준비가 되어 있습니다.

부문

DFU 치료제(창상 피복재, 생물제제, 치료 기기, 항생제 제제, 기타 DFU 치료제), DFU 치료 궤양 유형(신경장애성 궤양, 허혈성 궤양, 신경허혈성 궤양), DFU 치료 최종사용자(병원 최종사용자, 외래 수술 센터 최종사용자, 기타 최종사용자)

조사 대상 기업의 예

  • Abbott Laboratories
  • AnGes, Inc.
  • B. Braun Melsungen AG
  • Bayer AG
  • Boston Scientific Corporation
  • Cardiovascular Systems, Inc.
  • Cesca Therapeutics(ThermoGenesis Holdings, Inc)
  • Cook Medical
  • Cynata Therapeutics Ltd
  • Eli Lilly and Company
  • LimFlow SA
  • Medtronic plc
  • Micro Medical Solutions
  • Mitsubishi Tanabe Pharma Corporation
  • Pfizer Inc.
  • Pluristem Therapeutics Inc.
  • Rexgenero Ltd.
  • Sanofi
  • Terumo Corporation
  • Teva Pharmaceuticals

AI 통합

당사는 유효한 전문가 컨텐츠와 AI 툴에 의해 시장 정보와 경쟁 정보를 변혁하고 있습니다.

Global Industry Analysts는 일반적인 LLM나 업계별 SLM 쿼리에 따르는 대신에, 비디오 기록, 블로그, 검색 엔진 조사, 대량 기업, 제품/서비스, 시장 데이터 등, 전 세계 전문가로부터 수집한 컨텐츠 리포지토리를 구축했습니다.

관세 영향 계수

Global Industry Analysts는 본사 소재지, 제조거점, 수출입(완제품 및 OEM)을 기준으로 기업의 경쟁력 변화를 예측했습니다. 이러한 복잡하고 다면적인 시장 역학은 수입원가(COGS) 증가, 수익성 하락, 공급망 재편 등 미시적, 거시적 시장 역학 중에서도 특히 경쟁사들에게 영향을 미칠 것으로 예측됩니다.

목차

제1장 조사 방법

제2장 개요

  • 시장 개요
  • 주요 기업
  • 시장 동향과 촉진요인
  • 세계 시장 전망

제3장 시장 분석

  • 미국
  • 캐나다
  • 일본
  • 중국
  • 유럽
  • 프랑스
  • 독일
  • 이탈리아
  • 영국
  • 스페인
  • 러시아
  • 기타 유럽
  • 아시아태평양
  • 호주
  • 인도
  • 한국
  • 기타 아시아태평양
  • 라틴아메리카
  • 아르헨티나
  • 브라질
  • 멕시코
  • 기타 라틴아메리카
  • 중동
  • 이란
  • 이스라엘
  • 사우디아라비아
  • 아랍에미리트
  • 기타 중동
  • 아프리카

제4장 경쟁

KSA 25.08.06

Global Critical Limb Ischemia Treatment Market to Reach US$8.1 Billion by 2030

The global market for Critical Limb Ischemia Treatment estimated at US$5.6 Billion in the year 2024, is expected to reach US$8.1 Billion by 2030, growing at a CAGR of 6.5% over the analysis period 2024-2030. Wound Care Dressings, one of the segments analyzed in the report, is expected to record a 4.8% CAGR and reach US$2.8 Billion by the end of the analysis period. Growth in the Biologics segment is estimated at 8.2% CAGR over the analysis period.

The U.S. Market is Estimated at US$1.5 Billion While China is Forecast to Grow at 9.8% CAGR

The Critical Limb Ischemia Treatment market in the U.S. is estimated at US$1.5 Billion in the year 2024. China, the world's second largest economy, is forecast to reach a projected market size of US$1.6 Billion by the year 2030 trailing a CAGR of 9.8% over the analysis period 2024-2030. Among the other noteworthy geographic markets are Japan and Canada, each forecast to grow at a CAGR of 3.3% and 6.2% respectively over the analysis period. Within Europe, Germany is forecast to grow at approximately 4.2% CAGR.

Global Critical Limb Ischemia Treatment Market - Key Trends & Drivers Summarized

Why Is the Demand for Critical Limb Ischemia Treatment Increasing? Understanding the Rise in Peripheral Artery Disease Cases

The global critical limb ischemia (CLI) treatment market is witnessing rapid growth due to the increasing prevalence of peripheral artery disease (PAD), diabetes, and cardiovascular conditions. CLI is a severe form of PAD that leads to reduced blood flow in the lower extremities, often resulting in non-healing ulcers, gangrene, and amputation risks. As the global burden of chronic diseases rises, healthcare providers and pharmaceutical companies are focusing on advanced treatment options to improve patient outcomes. Aging populations, lifestyle-related risk factors, and the growing incidence of obesity have further fueled the demand for effective CLI therapies. Additionally, advancements in minimally invasive endovascular procedures and regenerative medicine have provided new hope for CLI patients.

What Are the Leading Treatment Options for Critical Limb Ischemia? Exploring Key Segments

The CLI treatment market consists of various therapeutic approaches, including revascularization procedures, pharmacological interventions, and emerging regenerative therapies. Endovascular treatments, such as angioplasty and stent placement, remain the gold standard for restoring blood flow in CLI patients, with newer drug-coated balloon technologies enhancing long-term efficacy. Surgical interventions, including bypass grafting, are also widely used for severe cases. Pharmacological treatments, including antiplatelet and anticoagulant therapies, play a critical role in preventing disease progression. Additionally, regenerative medicine approaches, such as stem cell therapy and gene-based treatments, have shown promising results in promoting vascular regeneration and wound healing. The integration of telemedicine and AI-driven diagnostics is further improving early detection and personalized treatment strategies.

How Is Technology Transforming CLI Treatment? The Role of AI, Biomaterials & Personalized Medicine

The field of CLI treatment is evolving with technological innovations in biomaterials, AI-driven diagnostics, and precision medicine. AI-powered imaging tools are enhancing early detection by analyzing vascular health and identifying ischemic regions with greater accuracy. The development of bioengineered vascular grafts and tissue scaffolds has improved treatment outcomes by providing long-lasting blood flow restoration. Additionally, advances in gene therapy and stem cell transplantation are offering potential regenerative solutions, reducing the need for amputation. Wearable health monitoring devices are also playing a role in tracking blood circulation, enabling real-time patient management. As personalized medicine gains traction, tailored therapeutic strategies based on genetic and metabolic profiles are improving CLI treatment efficacy.

What’s Driving the Growth of the CLI Treatment Market? Key Market Influencers Explained

The growth in the critical limb ischemia treatment market is driven by increasing disease prevalence, rising healthcare expenditures, and advancements in endovascular and regenerative therapies. The expansion of vascular surgery and interventional cardiology programs has improved access to advanced CLI treatments. Additionally, government initiatives promoting early screening and PAD awareness have contributed to higher diagnosis rates. The rise of value-based healthcare models has encouraged the development of cost-effective CLI therapies, making treatment more accessible to underserved populations. With continued research in novel vascular regeneration techniques and expanding global healthcare infrastructure, the CLI treatment market is poised for significant advancements and long-term growth.

SCOPE OF STUDY:

The report analyzes the Critical Limb Ischemia Treatment market in terms of units by the following Segments, and Geographic Regions/Countries:

Segments:

DFU Treatment (Wound Care Dressings, Biologics, Therapy Devices, Antibiotic Medications, Other DFU Treatments); DFU Treatment Ulcer Type (Neuropathic Ulcers, Ischemic Ulcers, Neuro-ischemic Ulcers); DFU Treatment End-Use (Hospital End-Use, Ambulatory Surgery Centre End-Use, Other End-Uses)

Geographic Regions/Countries:

World; United States; Canada; Japan; China; Europe (France; Germany; Italy; United Kingdom; Spain; Russia; and Rest of Europe); Asia-Pacific (Australia; India; South Korea; and Rest of Asia-Pacific); Latin America (Argentina; Brazil; Mexico; and Rest of Latin America); Middle East (Iran; Israel; Saudi Arabia; United Arab Emirates; and Rest of Middle East); and Africa.

Select Competitors (Total 36 Featured) -

  • Abbott Laboratories
  • AnGes, Inc.
  • B. Braun Melsungen AG
  • Bayer AG
  • Boston Scientific Corporation
  • Cardiovascular Systems, Inc.
  • Cesca Therapeutics (ThermoGenesis Holdings, Inc)
  • Cook Medical
  • Cynata Therapeutics Ltd
  • Eli Lilly and Company
  • LimFlow SA
  • Medtronic plc
  • Micro Medical Solutions
  • Mitsubishi Tanabe Pharma Corporation
  • Pfizer Inc.
  • Pluristem Therapeutics Inc.
  • Rexgenero Ltd.
  • Sanofi
  • Terumo Corporation
  • Teva Pharmaceuticals

AI INTEGRATIONS

We're transforming market and competitive intelligence with validated expert content and AI tools.

Instead of following the general norm of querying LLMs and Industry-specific SLMs, we built repositories of content curated from domain experts worldwide including video transcripts, blogs, search engines research, and massive amounts of enterprise, product/service, and market data.

TARIFF IMPACT FACTOR

Our new release incorporates impact of tariffs on geographical markets as we predict a shift in competitiveness of companies based on HQ country, manufacturing base, exports and imports (finished goods and OEM). This intricate and multifaceted market reality will impact competitors by increasing the Cost of Goods Sold (COGS), reducing profitability, reconfiguring supply chains, amongst other micro and macro market dynamics.

TABLE OF CONTENTS

I. METHODOLOGY

II. EXECUTIVE SUMMARY

  • 1. MARKET OVERVIEW
    • Influencer Market Insights
    • Tariff Impact on Global Supply Chain Patterns
    • Critical Limb Ischemia Treatment - Global Key Competitors Percentage Market Share in 2025 (E)
    • Competitive Market Presence - Strong/Active/Niche/Trivial for Players Worldwide in 2025 (E)
  • 2. FOCUS ON SELECT PLAYERS
  • 3. MARKET TRENDS & DRIVERS
    • Increasing Prevalence of Peripheral Arterial Disease (PAD) and Diabetes Drives Growth in Critical Limb Ischemia Treatment Demand
    • Rising Aging Population and Associated Vascular Diseases Expands Market Opportunity for CLI Treatment Solutions
    • Advancements in Endovascular Procedures Strengthen the Business Case for Minimally Invasive CLI Treatment Options
    • Surge in Smokers and Obesity Rates Expands Addressable Market for Critical Limb Ischemia Therapies
    • Increasing Focus on Early Detection and Prevention Strategies Propels Growth in CLI Treatment and Management Tools
    • Technological Innovations in Angioplasty and Stenting Devices Enhance Treatment Outcomes and Drive Adoption of CLI Therapies
    • Growing Adoption of Hybrid Surgical Procedures in CLI Treatment Spurs Demand for Advanced Vascular Interventions
    • Rising Demand for Personalized Medicine and Tailored Treatment Plans Accelerates Market Growth for CLI Therapies
    • Surge in Health Insurance Coverage and Healthcare Accessibility Expands the Market for CLI Treatment Solutions in Emerging Economies
    • Integration of Artificial Intelligence and Imaging Technologies in CLI Diagnosis and Treatment Drives Market Innovation
    • Increasing Use of Stem Cell and Regenerative Medicine Technologies in CLI Treatment Generates New Growth Opportunities
    • Rise in Healthcare Spending and Investment in Specialized Vascular Care Expands the Market for CLI Interventions
    • Growing Focus on Post-Surgery Recovery and Rehabilitation Drives Demand for CLI Treatment Solutions with Shorter Recovery Times
    • Regulatory Changes and Advancements in Clinical Guidelines for CLI Treatment Spur Market Adoption of New Therapeutic Options
    • The Emergence of Telemedicine and Remote Monitoring Solutions Expands Market Opportunity for Post-Treatment CLI Care
    • Rising Awareness of CLI and Vascular Health Challenges Accelerates Demand for Educational Campaigns and Screening Programs
    • Increasing Number of Clinical Trials and Research Projects on CLI Treatment Drives Innovation in Therapies and Technologies
    • Growing Emphasis on Non-Surgical Treatment Options Strengthens Demand for Drug Therapies and Endovenous Laser Therapies for CLI
    • Surge in Peripheral Endovascular Interventions for CLI Treatment Generates Opportunities for Cross-Specialty Collaboration in Healthcare
    • Focus on Minimizing Amputation Rates and Improving Limb Salvage Drives Adoption of Advanced CLI Treatment Modalities
  • 4. GLOBAL MARKET PERSPECTIVE
    • TABLE 1: World Critical Limb Ischemia Treatment Market Analysis of Annual Sales in US$ Million for Years 2015 through 2030
    • TABLE 2: World Recent Past, Current & Future Analysis for Critical Limb Ischemia Treatment by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
    • TABLE 3: World Historic Review for Critical Limb Ischemia Treatment by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 4: World 15-Year Perspective for Critical Limb Ischemia Treatment by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets for Years 2015, 2025 & 2030
    • TABLE 5: World Recent Past, Current & Future Analysis for Wound Care Dressings by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
    • TABLE 6: World Historic Review for Wound Care Dressings by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 7: World 15-Year Perspective for Wound Care Dressings by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2015, 2025 & 2030
    • TABLE 8: World Recent Past, Current & Future Analysis for Biologics by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
    • TABLE 9: World Historic Review for Biologics by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 10: World 15-Year Perspective for Biologics by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2015, 2025 & 2030
    • TABLE 11: World Recent Past, Current & Future Analysis for Therapy Devices by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
    • TABLE 12: World Historic Review for Therapy Devices by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 13: World 15-Year Perspective for Therapy Devices by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2015, 2025 & 2030
    • TABLE 14: World Recent Past, Current & Future Analysis for Antibiotic Medications by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
    • TABLE 15: World Historic Review for Antibiotic Medications by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 16: World 15-Year Perspective for Antibiotic Medications by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2015, 2025 & 2030
    • TABLE 17: World Recent Past, Current & Future Analysis for Other DFU Treatments by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
    • TABLE 18: World Historic Review for Other DFU Treatments by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 19: World 15-Year Perspective for Other DFU Treatments by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2015, 2025 & 2030
    • TABLE 20: World Recent Past, Current & Future Analysis for Ambulatory Surgery Centre End-Use by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
    • TABLE 21: World Historic Review for Ambulatory Surgery Centre End-Use by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 22: World 15-Year Perspective for Ambulatory Surgery Centre End-Use by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2015, 2025 & 2030
    • TABLE 23: World Recent Past, Current & Future Analysis for Other End-Uses by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
    • TABLE 24: World Historic Review for Other End-Uses by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 25: World 15-Year Perspective for Other End-Uses by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2015, 2025 & 2030
    • TABLE 26: World Recent Past, Current & Future Analysis for Hospital End-Use by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
    • TABLE 27: World Historic Review for Hospital End-Use by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 28: World 15-Year Perspective for Hospital End-Use by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2015, 2025 & 2030
    • TABLE 29: World Recent Past, Current & Future Analysis for Neuropathic Ulcers by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
    • TABLE 30: World Historic Review for Neuropathic Ulcers by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 31: World 15-Year Perspective for Neuropathic Ulcers by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2015, 2025 & 2030
    • TABLE 32: World Recent Past, Current & Future Analysis for Ischemic Ulcers by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
    • TABLE 33: World Historic Review for Ischemic Ulcers by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 34: World 15-Year Perspective for Ischemic Ulcers by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2015, 2025 & 2030
    • TABLE 35: World Recent Past, Current & Future Analysis for Neuro-ischemic Ulcers by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
    • TABLE 36: World Historic Review for Neuro-ischemic Ulcers by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 37: World 15-Year Perspective for Neuro-ischemic Ulcers by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2015, 2025 & 2030

III. MARKET ANALYSIS

  • UNITED STATES
    • Critical Limb Ischemia Treatment Market Presence - Strong/Active/Niche/Trivial - Key Competitors in the United States for 2025 (E)
    • TABLE 38: USA Recent Past, Current & Future Analysis for Critical Limb Ischemia Treatment by DFU Treatment - Wound Care Dressings, Biologics, Therapy Devices, Antibiotic Medications and Other DFU Treatments - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 39: USA Historic Review for Critical Limb Ischemia Treatment by DFU Treatment - Wound Care Dressings, Biologics, Therapy Devices, Antibiotic Medications and Other DFU Treatments Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 40: USA 15-Year Perspective for Critical Limb Ischemia Treatment by DFU Treatment - Percentage Breakdown of Value Sales for Wound Care Dressings, Biologics, Therapy Devices, Antibiotic Medications and Other DFU Treatments for the Years 2015, 2025 & 2030
    • TABLE 41: USA Recent Past, Current & Future Analysis for Critical Limb Ischemia Treatment by DFU Treatment End-Use - Ambulatory Surgery Centre End-Use, Other End-Uses and Hospital End-Use - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 42: USA Historic Review for Critical Limb Ischemia Treatment by DFU Treatment End-Use - Ambulatory Surgery Centre End-Use, Other End-Uses and Hospital End-Use Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 43: USA 15-Year Perspective for Critical Limb Ischemia Treatment by DFU Treatment End-Use - Percentage Breakdown of Value Sales for Ambulatory Surgery Centre End-Use, Other End-Uses and Hospital End-Use for the Years 2015, 2025 & 2030
    • TABLE 44: USA Recent Past, Current & Future Analysis for Critical Limb Ischemia Treatment by DFU Treatment Ulcer Type - Neuropathic Ulcers, Ischemic Ulcers and Neuro-ischemic Ulcers - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 45: USA Historic Review for Critical Limb Ischemia Treatment by DFU Treatment Ulcer Type - Neuropathic Ulcers, Ischemic Ulcers and Neuro-ischemic Ulcers Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 46: USA 15-Year Perspective for Critical Limb Ischemia Treatment by DFU Treatment Ulcer Type - Percentage Breakdown of Value Sales for Neuropathic Ulcers, Ischemic Ulcers and Neuro-ischemic Ulcers for the Years 2015, 2025 & 2030
  • CANADA
    • TABLE 47: Canada Recent Past, Current & Future Analysis for Critical Limb Ischemia Treatment by DFU Treatment - Wound Care Dressings, Biologics, Therapy Devices, Antibiotic Medications and Other DFU Treatments - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 48: Canada Historic Review for Critical Limb Ischemia Treatment by DFU Treatment - Wound Care Dressings, Biologics, Therapy Devices, Antibiotic Medications and Other DFU Treatments Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 49: Canada 15-Year Perspective for Critical Limb Ischemia Treatment by DFU Treatment - Percentage Breakdown of Value Sales for Wound Care Dressings, Biologics, Therapy Devices, Antibiotic Medications and Other DFU Treatments for the Years 2015, 2025 & 2030
    • TABLE 50: Canada Recent Past, Current & Future Analysis for Critical Limb Ischemia Treatment by DFU Treatment End-Use - Ambulatory Surgery Centre End-Use, Other End-Uses and Hospital End-Use - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 51: Canada Historic Review for Critical Limb Ischemia Treatment by DFU Treatment End-Use - Ambulatory Surgery Centre End-Use, Other End-Uses and Hospital End-Use Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 52: Canada 15-Year Perspective for Critical Limb Ischemia Treatment by DFU Treatment End-Use - Percentage Breakdown of Value Sales for Ambulatory Surgery Centre End-Use, Other End-Uses and Hospital End-Use for the Years 2015, 2025 & 2030
    • TABLE 53: Canada Recent Past, Current & Future Analysis for Critical Limb Ischemia Treatment by DFU Treatment Ulcer Type - Neuropathic Ulcers, Ischemic Ulcers and Neuro-ischemic Ulcers - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 54: Canada Historic Review for Critical Limb Ischemia Treatment by DFU Treatment Ulcer Type - Neuropathic Ulcers, Ischemic Ulcers and Neuro-ischemic Ulcers Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 55: Canada 15-Year Perspective for Critical Limb Ischemia Treatment by DFU Treatment Ulcer Type - Percentage Breakdown of Value Sales for Neuropathic Ulcers, Ischemic Ulcers and Neuro-ischemic Ulcers for the Years 2015, 2025 & 2030
  • JAPAN
    • Critical Limb Ischemia Treatment Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Japan for 2025 (E)
    • TABLE 56: Japan Recent Past, Current & Future Analysis for Critical Limb Ischemia Treatment by DFU Treatment - Wound Care Dressings, Biologics, Therapy Devices, Antibiotic Medications and Other DFU Treatments - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 57: Japan Historic Review for Critical Limb Ischemia Treatment by DFU Treatment - Wound Care Dressings, Biologics, Therapy Devices, Antibiotic Medications and Other DFU Treatments Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 58: Japan 15-Year Perspective for Critical Limb Ischemia Treatment by DFU Treatment - Percentage Breakdown of Value Sales for Wound Care Dressings, Biologics, Therapy Devices, Antibiotic Medications and Other DFU Treatments for the Years 2015, 2025 & 2030
    • TABLE 59: Japan Recent Past, Current & Future Analysis for Critical Limb Ischemia Treatment by DFU Treatment End-Use - Ambulatory Surgery Centre End-Use, Other End-Uses and Hospital End-Use - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 60: Japan Historic Review for Critical Limb Ischemia Treatment by DFU Treatment End-Use - Ambulatory Surgery Centre End-Use, Other End-Uses and Hospital End-Use Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 61: Japan 15-Year Perspective for Critical Limb Ischemia Treatment by DFU Treatment End-Use - Percentage Breakdown of Value Sales for Ambulatory Surgery Centre End-Use, Other End-Uses and Hospital End-Use for the Years 2015, 2025 & 2030
    • TABLE 62: Japan Recent Past, Current & Future Analysis for Critical Limb Ischemia Treatment by DFU Treatment Ulcer Type - Neuropathic Ulcers, Ischemic Ulcers and Neuro-ischemic Ulcers - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 63: Japan Historic Review for Critical Limb Ischemia Treatment by DFU Treatment Ulcer Type - Neuropathic Ulcers, Ischemic Ulcers and Neuro-ischemic Ulcers Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 64: Japan 15-Year Perspective for Critical Limb Ischemia Treatment by DFU Treatment Ulcer Type - Percentage Breakdown of Value Sales for Neuropathic Ulcers, Ischemic Ulcers and Neuro-ischemic Ulcers for the Years 2015, 2025 & 2030
  • CHINA
    • Critical Limb Ischemia Treatment Market Presence - Strong/Active/Niche/Trivial - Key Competitors in China for 2025 (E)
    • TABLE 65: China Recent Past, Current & Future Analysis for Critical Limb Ischemia Treatment by DFU Treatment - Wound Care Dressings, Biologics, Therapy Devices, Antibiotic Medications and Other DFU Treatments - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 66: China Historic Review for Critical Limb Ischemia Treatment by DFU Treatment - Wound Care Dressings, Biologics, Therapy Devices, Antibiotic Medications and Other DFU Treatments Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 67: China 15-Year Perspective for Critical Limb Ischemia Treatment by DFU Treatment - Percentage Breakdown of Value Sales for Wound Care Dressings, Biologics, Therapy Devices, Antibiotic Medications and Other DFU Treatments for the Years 2015, 2025 & 2030
    • TABLE 68: China Recent Past, Current & Future Analysis for Critical Limb Ischemia Treatment by DFU Treatment End-Use - Ambulatory Surgery Centre End-Use, Other End-Uses and Hospital End-Use - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 69: China Historic Review for Critical Limb Ischemia Treatment by DFU Treatment End-Use - Ambulatory Surgery Centre End-Use, Other End-Uses and Hospital End-Use Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 70: China 15-Year Perspective for Critical Limb Ischemia Treatment by DFU Treatment End-Use - Percentage Breakdown of Value Sales for Ambulatory Surgery Centre End-Use, Other End-Uses and Hospital End-Use for the Years 2015, 2025 & 2030
    • TABLE 71: China Recent Past, Current & Future Analysis for Critical Limb Ischemia Treatment by DFU Treatment Ulcer Type - Neuropathic Ulcers, Ischemic Ulcers and Neuro-ischemic Ulcers - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 72: China Historic Review for Critical Limb Ischemia Treatment by DFU Treatment Ulcer Type - Neuropathic Ulcers, Ischemic Ulcers and Neuro-ischemic Ulcers Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 73: China 15-Year Perspective for Critical Limb Ischemia Treatment by DFU Treatment Ulcer Type - Percentage Breakdown of Value Sales for Neuropathic Ulcers, Ischemic Ulcers and Neuro-ischemic Ulcers for the Years 2015, 2025 & 2030
  • EUROPE
    • Critical Limb Ischemia Treatment Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Europe for 2025 (E)
    • TABLE 74: Europe Recent Past, Current & Future Analysis for Critical Limb Ischemia Treatment by Geographic Region - France, Germany, Italy, UK, Spain, Russia and Rest of Europe Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
    • TABLE 75: Europe Historic Review for Critical Limb Ischemia Treatment by Geographic Region - France, Germany, Italy, UK, Spain, Russia and Rest of Europe Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 76: Europe 15-Year Perspective for Critical Limb Ischemia Treatment by Geographic Region - Percentage Breakdown of Value Sales for France, Germany, Italy, UK, Spain, Russia and Rest of Europe Markets for Years 2015, 2025 & 2030
    • TABLE 77: Europe Recent Past, Current & Future Analysis for Critical Limb Ischemia Treatment by DFU Treatment - Wound Care Dressings, Biologics, Therapy Devices, Antibiotic Medications and Other DFU Treatments - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 78: Europe Historic Review for Critical Limb Ischemia Treatment by DFU Treatment - Wound Care Dressings, Biologics, Therapy Devices, Antibiotic Medications and Other DFU Treatments Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 79: Europe 15-Year Perspective for Critical Limb Ischemia Treatment by DFU Treatment - Percentage Breakdown of Value Sales for Wound Care Dressings, Biologics, Therapy Devices, Antibiotic Medications and Other DFU Treatments for the Years 2015, 2025 & 2030
    • TABLE 80: Europe Recent Past, Current & Future Analysis for Critical Limb Ischemia Treatment by DFU Treatment End-Use - Ambulatory Surgery Centre End-Use, Other End-Uses and Hospital End-Use - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 81: Europe Historic Review for Critical Limb Ischemia Treatment by DFU Treatment End-Use - Ambulatory Surgery Centre End-Use, Other End-Uses and Hospital End-Use Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 82: Europe 15-Year Perspective for Critical Limb Ischemia Treatment by DFU Treatment End-Use - Percentage Breakdown of Value Sales for Ambulatory Surgery Centre End-Use, Other End-Uses and Hospital End-Use for the Years 2015, 2025 & 2030
    • TABLE 83: Europe Recent Past, Current & Future Analysis for Critical Limb Ischemia Treatment by DFU Treatment Ulcer Type - Neuropathic Ulcers, Ischemic Ulcers and Neuro-ischemic Ulcers - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 84: Europe Historic Review for Critical Limb Ischemia Treatment by DFU Treatment Ulcer Type - Neuropathic Ulcers, Ischemic Ulcers and Neuro-ischemic Ulcers Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 85: Europe 15-Year Perspective for Critical Limb Ischemia Treatment by DFU Treatment Ulcer Type - Percentage Breakdown of Value Sales for Neuropathic Ulcers, Ischemic Ulcers and Neuro-ischemic Ulcers for the Years 2015, 2025 & 2030
  • FRANCE
    • Critical Limb Ischemia Treatment Market Presence - Strong/Active/Niche/Trivial - Key Competitors in France for 2025 (E)
    • TABLE 86: France Recent Past, Current & Future Analysis for Critical Limb Ischemia Treatment by DFU Treatment - Wound Care Dressings, Biologics, Therapy Devices, Antibiotic Medications and Other DFU Treatments - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 87: France Historic Review for Critical Limb Ischemia Treatment by DFU Treatment - Wound Care Dressings, Biologics, Therapy Devices, Antibiotic Medications and Other DFU Treatments Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 88: France 15-Year Perspective for Critical Limb Ischemia Treatment by DFU Treatment - Percentage Breakdown of Value Sales for Wound Care Dressings, Biologics, Therapy Devices, Antibiotic Medications and Other DFU Treatments for the Years 2015, 2025 & 2030
    • TABLE 89: France Recent Past, Current & Future Analysis for Critical Limb Ischemia Treatment by DFU Treatment End-Use - Ambulatory Surgery Centre End-Use, Other End-Uses and Hospital End-Use - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 90: France Historic Review for Critical Limb Ischemia Treatment by DFU Treatment End-Use - Ambulatory Surgery Centre End-Use, Other End-Uses and Hospital End-Use Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 91: France 15-Year Perspective for Critical Limb Ischemia Treatment by DFU Treatment End-Use - Percentage Breakdown of Value Sales for Ambulatory Surgery Centre End-Use, Other End-Uses and Hospital End-Use for the Years 2015, 2025 & 2030
    • TABLE 92: France Recent Past, Current & Future Analysis for Critical Limb Ischemia Treatment by DFU Treatment Ulcer Type - Neuropathic Ulcers, Ischemic Ulcers and Neuro-ischemic Ulcers - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 93: France Historic Review for Critical Limb Ischemia Treatment by DFU Treatment Ulcer Type - Neuropathic Ulcers, Ischemic Ulcers and Neuro-ischemic Ulcers Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 94: France 15-Year Perspective for Critical Limb Ischemia Treatment by DFU Treatment Ulcer Type - Percentage Breakdown of Value Sales for Neuropathic Ulcers, Ischemic Ulcers and Neuro-ischemic Ulcers for the Years 2015, 2025 & 2030
  • GERMANY
    • Critical Limb Ischemia Treatment Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Germany for 2025 (E)
    • TABLE 95: Germany Recent Past, Current & Future Analysis for Critical Limb Ischemia Treatment by DFU Treatment - Wound Care Dressings, Biologics, Therapy Devices, Antibiotic Medications and Other DFU Treatments - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 96: Germany Historic Review for Critical Limb Ischemia Treatment by DFU Treatment - Wound Care Dressings, Biologics, Therapy Devices, Antibiotic Medications and Other DFU Treatments Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 97: Germany 15-Year Perspective for Critical Limb Ischemia Treatment by DFU Treatment - Percentage Breakdown of Value Sales for Wound Care Dressings, Biologics, Therapy Devices, Antibiotic Medications and Other DFU Treatments for the Years 2015, 2025 & 2030
    • TABLE 98: Germany Recent Past, Current & Future Analysis for Critical Limb Ischemia Treatment by DFU Treatment End-Use - Ambulatory Surgery Centre End-Use, Other End-Uses and Hospital End-Use - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 99: Germany Historic Review for Critical Limb Ischemia Treatment by DFU Treatment End-Use - Ambulatory Surgery Centre End-Use, Other End-Uses and Hospital End-Use Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 100: Germany 15-Year Perspective for Critical Limb Ischemia Treatment by DFU Treatment End-Use - Percentage Breakdown of Value Sales for Ambulatory Surgery Centre End-Use, Other End-Uses and Hospital End-Use for the Years 2015, 2025 & 2030
    • TABLE 101: Germany Recent Past, Current & Future Analysis for Critical Limb Ischemia Treatment by DFU Treatment Ulcer Type - Neuropathic Ulcers, Ischemic Ulcers and Neuro-ischemic Ulcers - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 102: Germany Historic Review for Critical Limb Ischemia Treatment by DFU Treatment Ulcer Type - Neuropathic Ulcers, Ischemic Ulcers and Neuro-ischemic Ulcers Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 103: Germany 15-Year Perspective for Critical Limb Ischemia Treatment by DFU Treatment Ulcer Type - Percentage Breakdown of Value Sales for Neuropathic Ulcers, Ischemic Ulcers and Neuro-ischemic Ulcers for the Years 2015, 2025 & 2030
  • ITALY
    • TABLE 104: Italy Recent Past, Current & Future Analysis for Critical Limb Ischemia Treatment by DFU Treatment - Wound Care Dressings, Biologics, Therapy Devices, Antibiotic Medications and Other DFU Treatments - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 105: Italy Historic Review for Critical Limb Ischemia Treatment by DFU Treatment - Wound Care Dressings, Biologics, Therapy Devices, Antibiotic Medications and Other DFU Treatments Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 106: Italy 15-Year Perspective for Critical Limb Ischemia Treatment by DFU Treatment - Percentage Breakdown of Value Sales for Wound Care Dressings, Biologics, Therapy Devices, Antibiotic Medications and Other DFU Treatments for the Years 2015, 2025 & 2030
    • TABLE 107: Italy Recent Past, Current & Future Analysis for Critical Limb Ischemia Treatment by DFU Treatment End-Use - Ambulatory Surgery Centre End-Use, Other End-Uses and Hospital End-Use - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 108: Italy Historic Review for Critical Limb Ischemia Treatment by DFU Treatment End-Use - Ambulatory Surgery Centre End-Use, Other End-Uses and Hospital End-Use Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 109: Italy 15-Year Perspective for Critical Limb Ischemia Treatment by DFU Treatment End-Use - Percentage Breakdown of Value Sales for Ambulatory Surgery Centre End-Use, Other End-Uses and Hospital End-Use for the Years 2015, 2025 & 2030
    • TABLE 110: Italy Recent Past, Current & Future Analysis for Critical Limb Ischemia Treatment by DFU Treatment Ulcer Type - Neuropathic Ulcers, Ischemic Ulcers and Neuro-ischemic Ulcers - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 111: Italy Historic Review for Critical Limb Ischemia Treatment by DFU Treatment Ulcer Type - Neuropathic Ulcers, Ischemic Ulcers and Neuro-ischemic Ulcers Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 112: Italy 15-Year Perspective for Critical Limb Ischemia Treatment by DFU Treatment Ulcer Type - Percentage Breakdown of Value Sales for Neuropathic Ulcers, Ischemic Ulcers and Neuro-ischemic Ulcers for the Years 2015, 2025 & 2030
  • UNITED KINGDOM
    • Critical Limb Ischemia Treatment Market Presence - Strong/Active/Niche/Trivial - Key Competitors in the United Kingdom for 2025 (E)
    • TABLE 113: UK Recent Past, Current & Future Analysis for Critical Limb Ischemia Treatment by DFU Treatment - Wound Care Dressings, Biologics, Therapy Devices, Antibiotic Medications and Other DFU Treatments - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 114: UK Historic Review for Critical Limb Ischemia Treatment by DFU Treatment - Wound Care Dressings, Biologics, Therapy Devices, Antibiotic Medications and Other DFU Treatments Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 115: UK 15-Year Perspective for Critical Limb Ischemia Treatment by DFU Treatment - Percentage Breakdown of Value Sales for Wound Care Dressings, Biologics, Therapy Devices, Antibiotic Medications and Other DFU Treatments for the Years 2015, 2025 & 2030
    • TABLE 116: UK Recent Past, Current & Future Analysis for Critical Limb Ischemia Treatment by DFU Treatment End-Use - Ambulatory Surgery Centre End-Use, Other End-Uses and Hospital End-Use - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 117: UK Historic Review for Critical Limb Ischemia Treatment by DFU Treatment End-Use - Ambulatory Surgery Centre End-Use, Other End-Uses and Hospital End-Use Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 118: UK 15-Year Perspective for Critical Limb Ischemia Treatment by DFU Treatment End-Use - Percentage Breakdown of Value Sales for Ambulatory Surgery Centre End-Use, Other End-Uses and Hospital End-Use for the Years 2015, 2025 & 2030
    • TABLE 119: UK Recent Past, Current & Future Analysis for Critical Limb Ischemia Treatment by DFU Treatment Ulcer Type - Neuropathic Ulcers, Ischemic Ulcers and Neuro-ischemic Ulcers - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 120: UK Historic Review for Critical Limb Ischemia Treatment by DFU Treatment Ulcer Type - Neuropathic Ulcers, Ischemic Ulcers and Neuro-ischemic Ulcers Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 121: UK 15-Year Perspective for Critical Limb Ischemia Treatment by DFU Treatment Ulcer Type - Percentage Breakdown of Value Sales for Neuropathic Ulcers, Ischemic Ulcers and Neuro-ischemic Ulcers for the Years 2015, 2025 & 2030
  • SPAIN
    • TABLE 122: Spain Recent Past, Current & Future Analysis for Critical Limb Ischemia Treatment by DFU Treatment - Wound Care Dressings, Biologics, Therapy Devices, Antibiotic Medications and Other DFU Treatments - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 123: Spain Historic Review for Critical Limb Ischemia Treatment by DFU Treatment - Wound Care Dressings, Biologics, Therapy Devices, Antibiotic Medications and Other DFU Treatments Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 124: Spain 15-Year Perspective for Critical Limb Ischemia Treatment by DFU Treatment - Percentage Breakdown of Value Sales for Wound Care Dressings, Biologics, Therapy Devices, Antibiotic Medications and Other DFU Treatments for the Years 2015, 2025 & 2030
    • TABLE 125: Spain Recent Past, Current & Future Analysis for Critical Limb Ischemia Treatment by DFU Treatment End-Use - Ambulatory Surgery Centre End-Use, Other End-Uses and Hospital End-Use - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 126: Spain Historic Review for Critical Limb Ischemia Treatment by DFU Treatment End-Use - Ambulatory Surgery Centre End-Use, Other End-Uses and Hospital End-Use Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 127: Spain 15-Year Perspective for Critical Limb Ischemia Treatment by DFU Treatment End-Use - Percentage Breakdown of Value Sales for Ambulatory Surgery Centre End-Use, Other End-Uses and Hospital End-Use for the Years 2015, 2025 & 2030
    • TABLE 128: Spain Recent Past, Current & Future Analysis for Critical Limb Ischemia Treatment by DFU Treatment Ulcer Type - Neuropathic Ulcers, Ischemic Ulcers and Neuro-ischemic Ulcers - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 129: Spain Historic Review for Critical Limb Ischemia Treatment by DFU Treatment Ulcer Type - Neuropathic Ulcers, Ischemic Ulcers and Neuro-ischemic Ulcers Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 130: Spain 15-Year Perspective for Critical Limb Ischemia Treatment by DFU Treatment Ulcer Type - Percentage Breakdown of Value Sales for Neuropathic Ulcers, Ischemic Ulcers and Neuro-ischemic Ulcers for the Years 2015, 2025 & 2030
  • RUSSIA
    • TABLE 131: Russia Recent Past, Current & Future Analysis for Critical Limb Ischemia Treatment by DFU Treatment - Wound Care Dressings, Biologics, Therapy Devices, Antibiotic Medications and Other DFU Treatments - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 132: Russia Historic Review for Critical Limb Ischemia Treatment by DFU Treatment - Wound Care Dressings, Biologics, Therapy Devices, Antibiotic Medications and Other DFU Treatments Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 133: Russia 15-Year Perspective for Critical Limb Ischemia Treatment by DFU Treatment - Percentage Breakdown of Value Sales for Wound Care Dressings, Biologics, Therapy Devices, Antibiotic Medications and Other DFU Treatments for the Years 2015, 2025 & 2030
    • TABLE 134: Russia Recent Past, Current & Future Analysis for Critical Limb Ischemia Treatment by DFU Treatment End-Use - Ambulatory Surgery Centre End-Use, Other End-Uses and Hospital End-Use - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 135: Russia Historic Review for Critical Limb Ischemia Treatment by DFU Treatment End-Use - Ambulatory Surgery Centre End-Use, Other End-Uses and Hospital End-Use Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 136: Russia 15-Year Perspective for Critical Limb Ischemia Treatment by DFU Treatment End-Use - Percentage Breakdown of Value Sales for Ambulatory Surgery Centre End-Use, Other End-Uses and Hospital End-Use for the Years 2015, 2025 & 2030
    • TABLE 137: Russia Recent Past, Current & Future Analysis for Critical Limb Ischemia Treatment by DFU Treatment Ulcer Type - Neuropathic Ulcers, Ischemic Ulcers and Neuro-ischemic Ulcers - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 138: Russia Historic Review for Critical Limb Ischemia Treatment by DFU Treatment Ulcer Type - Neuropathic Ulcers, Ischemic Ulcers and Neuro-ischemic Ulcers Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 139: Russia 15-Year Perspective for Critical Limb Ischemia Treatment by DFU Treatment Ulcer Type - Percentage Breakdown of Value Sales for Neuropathic Ulcers, Ischemic Ulcers and Neuro-ischemic Ulcers for the Years 2015, 2025 & 2030
  • REST OF EUROPE
    • TABLE 140: Rest of Europe Recent Past, Current & Future Analysis for Critical Limb Ischemia Treatment by DFU Treatment - Wound Care Dressings, Biologics, Therapy Devices, Antibiotic Medications and Other DFU Treatments - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 141: Rest of Europe Historic Review for Critical Limb Ischemia Treatment by DFU Treatment - Wound Care Dressings, Biologics, Therapy Devices, Antibiotic Medications and Other DFU Treatments Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 142: Rest of Europe 15-Year Perspective for Critical Limb Ischemia Treatment by DFU Treatment - Percentage Breakdown of Value Sales for Wound Care Dressings, Biologics, Therapy Devices, Antibiotic Medications and Other DFU Treatments for the Years 2015, 2025 & 2030
    • TABLE 143: Rest of Europe Recent Past, Current & Future Analysis for Critical Limb Ischemia Treatment by DFU Treatment End-Use - Ambulatory Surgery Centre End-Use, Other End-Uses and Hospital End-Use - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 144: Rest of Europe Historic Review for Critical Limb Ischemia Treatment by DFU Treatment End-Use - Ambulatory Surgery Centre End-Use, Other End-Uses and Hospital End-Use Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 145: Rest of Europe 15-Year Perspective for Critical Limb Ischemia Treatment by DFU Treatment End-Use - Percentage Breakdown of Value Sales for Ambulatory Surgery Centre End-Use, Other End-Uses and Hospital End-Use for the Years 2015, 2025 & 2030
    • TABLE 146: Rest of Europe Recent Past, Current & Future Analysis for Critical Limb Ischemia Treatment by DFU Treatment Ulcer Type - Neuropathic Ulcers, Ischemic Ulcers and Neuro-ischemic Ulcers - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 147: Rest of Europe Historic Review for Critical Limb Ischemia Treatment by DFU Treatment Ulcer Type - Neuropathic Ulcers, Ischemic Ulcers and Neuro-ischemic Ulcers Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 148: Rest of Europe 15-Year Perspective for Critical Limb Ischemia Treatment by DFU Treatment Ulcer Type - Percentage Breakdown of Value Sales for Neuropathic Ulcers, Ischemic Ulcers and Neuro-ischemic Ulcers for the Years 2015, 2025 & 2030
  • ASIA-PACIFIC
    • Critical Limb Ischemia Treatment Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Asia-Pacific for 2025 (E)
    • TABLE 149: Asia-Pacific Recent Past, Current & Future Analysis for Critical Limb Ischemia Treatment by Geographic Region - Australia, India, South Korea and Rest of Asia-Pacific Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
    • TABLE 150: Asia-Pacific Historic Review for Critical Limb Ischemia Treatment by Geographic Region - Australia, India, South Korea and Rest of Asia-Pacific Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 151: Asia-Pacific 15-Year Perspective for Critical Limb Ischemia Treatment by Geographic Region - Percentage Breakdown of Value Sales for Australia, India, South Korea and Rest of Asia-Pacific Markets for Years 2015, 2025 & 2030
    • TABLE 152: Asia-Pacific Recent Past, Current & Future Analysis for Critical Limb Ischemia Treatment by DFU Treatment - Wound Care Dressings, Biologics, Therapy Devices, Antibiotic Medications and Other DFU Treatments - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 153: Asia-Pacific Historic Review for Critical Limb Ischemia Treatment by DFU Treatment - Wound Care Dressings, Biologics, Therapy Devices, Antibiotic Medications and Other DFU Treatments Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 154: Asia-Pacific 15-Year Perspective for Critical Limb Ischemia Treatment by DFU Treatment - Percentage Breakdown of Value Sales for Wound Care Dressings, Biologics, Therapy Devices, Antibiotic Medications and Other DFU Treatments for the Years 2015, 2025 & 2030
    • TABLE 155: Asia-Pacific Recent Past, Current & Future Analysis for Critical Limb Ischemia Treatment by DFU Treatment End-Use - Ambulatory Surgery Centre End-Use, Other End-Uses and Hospital End-Use - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 156: Asia-Pacific Historic Review for Critical Limb Ischemia Treatment by DFU Treatment End-Use - Ambulatory Surgery Centre End-Use, Other End-Uses and Hospital End-Use Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 157: Asia-Pacific 15-Year Perspective for Critical Limb Ischemia Treatment by DFU Treatment End-Use - Percentage Breakdown of Value Sales for Ambulatory Surgery Centre End-Use, Other End-Uses and Hospital End-Use for the Years 2015, 2025 & 2030
    • TABLE 158: Asia-Pacific Recent Past, Current & Future Analysis for Critical Limb Ischemia Treatment by DFU Treatment Ulcer Type - Neuropathic Ulcers, Ischemic Ulcers and Neuro-ischemic Ulcers - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 159: Asia-Pacific Historic Review for Critical Limb Ischemia Treatment by DFU Treatment Ulcer Type - Neuropathic Ulcers, Ischemic Ulcers and Neuro-ischemic Ulcers Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 160: Asia-Pacific 15-Year Perspective for Critical Limb Ischemia Treatment by DFU Treatment Ulcer Type - Percentage Breakdown of Value Sales for Neuropathic Ulcers, Ischemic Ulcers and Neuro-ischemic Ulcers for the Years 2015, 2025 & 2030
  • AUSTRALIA
    • Critical Limb Ischemia Treatment Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Australia for 2025 (E)
    • TABLE 161: Australia Recent Past, Current & Future Analysis for Critical Limb Ischemia Treatment by DFU Treatment - Wound Care Dressings, Biologics, Therapy Devices, Antibiotic Medications and Other DFU Treatments - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 162: Australia Historic Review for Critical Limb Ischemia Treatment by DFU Treatment - Wound Care Dressings, Biologics, Therapy Devices, Antibiotic Medications and Other DFU Treatments Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 163: Australia 15-Year Perspective for Critical Limb Ischemia Treatment by DFU Treatment - Percentage Breakdown of Value Sales for Wound Care Dressings, Biologics, Therapy Devices, Antibiotic Medications and Other DFU Treatments for the Years 2015, 2025 & 2030
    • TABLE 164: Australia Recent Past, Current & Future Analysis for Critical Limb Ischemia Treatment by DFU Treatment End-Use - Ambulatory Surgery Centre End-Use, Other End-Uses and Hospital End-Use - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 165: Australia Historic Review for Critical Limb Ischemia Treatment by DFU Treatment End-Use - Ambulatory Surgery Centre End-Use, Other End-Uses and Hospital End-Use Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 166: Australia 15-Year Perspective for Critical Limb Ischemia Treatment by DFU Treatment End-Use - Percentage Breakdown of Value Sales for Ambulatory Surgery Centre End-Use, Other End-Uses and Hospital End-Use for the Years 2015, 2025 & 2030
    • TABLE 167: Australia Recent Past, Current & Future Analysis for Critical Limb Ischemia Treatment by DFU Treatment Ulcer Type - Neuropathic Ulcers, Ischemic Ulcers and Neuro-ischemic Ulcers - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 168: Australia Historic Review for Critical Limb Ischemia Treatment by DFU Treatment Ulcer Type - Neuropathic Ulcers, Ischemic Ulcers and Neuro-ischemic Ulcers Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 169: Australia 15-Year Perspective for Critical Limb Ischemia Treatment by DFU Treatment Ulcer Type - Percentage Breakdown of Value Sales for Neuropathic Ulcers, Ischemic Ulcers and Neuro-ischemic Ulcers for the Years 2015, 2025 & 2030
  • INDIA
    • Critical Limb Ischemia Treatment Market Presence - Strong/Active/Niche/Trivial - Key Competitors in India for 2025 (E)
    • TABLE 170: India Recent Past, Current & Future Analysis for Critical Limb Ischemia Treatment by DFU Treatment - Wound Care Dressings, Biologics, Therapy Devices, Antibiotic Medications and Other DFU Treatments - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 171: India Historic Review for Critical Limb Ischemia Treatment by DFU Treatment - Wound Care Dressings, Biologics, Therapy Devices, Antibiotic Medications and Other DFU Treatments Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 172: India 15-Year Perspective for Critical Limb Ischemia Treatment by DFU Treatment - Percentage Breakdown of Value Sales for Wound Care Dressings, Biologics, Therapy Devices, Antibiotic Medications and Other DFU Treatments for the Years 2015, 2025 & 2030
    • TABLE 173: India Recent Past, Current & Future Analysis for Critical Limb Ischemia Treatment by DFU Treatment End-Use - Ambulatory Surgery Centre End-Use, Other End-Uses and Hospital End-Use - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 174: India Historic Review for Critical Limb Ischemia Treatment by DFU Treatment End-Use - Ambulatory Surgery Centre End-Use, Other End-Uses and Hospital End-Use Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 175: India 15-Year Perspective for Critical Limb Ischemia Treatment by DFU Treatment End-Use - Percentage Breakdown of Value Sales for Ambulatory Surgery Centre End-Use, Other End-Uses and Hospital End-Use for the Years 2015, 2025 & 2030
    • TABLE 176: India Recent Past, Current & Future Analysis for Critical Limb Ischemia Treatment by DFU Treatment Ulcer Type - Neuropathic Ulcers, Ischemic Ulcers and Neuro-ischemic Ulcers - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 177: India Historic Review for Critical Limb Ischemia Treatment by DFU Treatment Ulcer Type - Neuropathic Ulcers, Ischemic Ulcers and Neuro-ischemic Ulcers Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 178: India 15-Year Perspective for Critical Limb Ischemia Treatment by DFU Treatment Ulcer Type - Percentage Breakdown of Value Sales for Neuropathic Ulcers, Ischemic Ulcers and Neuro-ischemic Ulcers for the Years 2015, 2025 & 2030
  • SOUTH KOREA
    • TABLE 179: South Korea Recent Past, Current & Future Analysis for Critical Limb Ischemia Treatment by DFU Treatment - Wound Care Dressings, Biologics, Therapy Devices, Antibiotic Medications and Other DFU Treatments - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 180: South Korea Historic Review for Critical Limb Ischemia Treatment by DFU Treatment - Wound Care Dressings, Biologics, Therapy Devices, Antibiotic Medications and Other DFU Treatments Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 181: South Korea 15-Year Perspective for Critical Limb Ischemia Treatment by DFU Treatment - Percentage Breakdown of Value Sales for Wound Care Dressings, Biologics, Therapy Devices, Antibiotic Medications and Other DFU Treatments for the Years 2015, 2025 & 2030
    • TABLE 182: South Korea Recent Past, Current & Future Analysis for Critical Limb Ischemia Treatment by DFU Treatment End-Use - Ambulatory Surgery Centre End-Use, Other End-Uses and Hospital End-Use - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 183: South Korea Historic Review for Critical Limb Ischemia Treatment by DFU Treatment End-Use - Ambulatory Surgery Centre End-Use, Other End-Uses and Hospital End-Use Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 184: South Korea 15-Year Perspective for Critical Limb Ischemia Treatment by DFU Treatment End-Use - Percentage Breakdown of Value Sales for Ambulatory Surgery Centre End-Use, Other End-Uses and Hospital End-Use for the Years 2015, 2025 & 2030
    • TABLE 185: South Korea Recent Past, Current & Future Analysis for Critical Limb Ischemia Treatment by DFU Treatment Ulcer Type - Neuropathic Ulcers, Ischemic Ulcers and Neuro-ischemic Ulcers - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 186: South Korea Historic Review for Critical Limb Ischemia Treatment by DFU Treatment Ulcer Type - Neuropathic Ulcers, Ischemic Ulcers and Neuro-ischemic Ulcers Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 187: South Korea 15-Year Perspective for Critical Limb Ischemia Treatment by DFU Treatment Ulcer Type - Percentage Breakdown of Value Sales for Neuropathic Ulcers, Ischemic Ulcers and Neuro-ischemic Ulcers for the Years 2015, 2025 & 2030
  • REST OF ASIA-PACIFIC
    • TABLE 188: Rest of Asia-Pacific Recent Past, Current & Future Analysis for Critical Limb Ischemia Treatment by DFU Treatment - Wound Care Dressings, Biologics, Therapy Devices, Antibiotic Medications and Other DFU Treatments - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 189: Rest of Asia-Pacific Historic Review for Critical Limb Ischemia Treatment by DFU Treatment - Wound Care Dressings, Biologics, Therapy Devices, Antibiotic Medications and Other DFU Treatments Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 190: Rest of Asia-Pacific 15-Year Perspective for Critical Limb Ischemia Treatment by DFU Treatment - Percentage Breakdown of Value Sales for Wound Care Dressings, Biologics, Therapy Devices, Antibiotic Medications and Other DFU Treatments for the Years 2015, 2025 & 2030
    • TABLE 191: Rest of Asia-Pacific Recent Past, Current & Future Analysis for Critical Limb Ischemia Treatment by DFU Treatment End-Use - Ambulatory Surgery Centre End-Use, Other End-Uses and Hospital End-Use - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 192: Rest of Asia-Pacific Historic Review for Critical Limb Ischemia Treatment by DFU Treatment End-Use - Ambulatory Surgery Centre End-Use, Other End-Uses and Hospital End-Use Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 193: Rest of Asia-Pacific 15-Year Perspective for Critical Limb Ischemia Treatment by DFU Treatment End-Use - Percentage Breakdown of Value Sales for Ambulatory Surgery Centre End-Use, Other End-Uses and Hospital End-Use for the Years 2015, 2025 & 2030
    • TABLE 194: Rest of Asia-Pacific Recent Past, Current & Future Analysis for Critical Limb Ischemia Treatment by DFU Treatment Ulcer Type - Neuropathic Ulcers, Ischemic Ulcers and Neuro-ischemic Ulcers - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 195: Rest of Asia-Pacific Historic Review for Critical Limb Ischemia Treatment by DFU Treatment Ulcer Type - Neuropathic Ulcers, Ischemic Ulcers and Neuro-ischemic Ulcers Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 196: Rest of Asia-Pacific 15-Year Perspective for Critical Limb Ischemia Treatment by DFU Treatment Ulcer Type - Percentage Breakdown of Value Sales for Neuropathic Ulcers, Ischemic Ulcers and Neuro-ischemic Ulcers for the Years 2015, 2025 & 2030
  • LATIN AMERICA
    • Critical Limb Ischemia Treatment Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Latin America for 2025 (E)
    • TABLE 197: Latin America Recent Past, Current & Future Analysis for Critical Limb Ischemia Treatment by Geographic Region - Argentina, Brazil, Mexico and Rest of Latin America Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
    • TABLE 198: Latin America Historic Review for Critical Limb Ischemia Treatment by Geographic Region - Argentina, Brazil, Mexico and Rest of Latin America Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 199: Latin America 15-Year Perspective for Critical Limb Ischemia Treatment by Geographic Region - Percentage Breakdown of Value Sales for Argentina, Brazil, Mexico and Rest of Latin America Markets for Years 2015, 2025 & 2030
    • TABLE 200: Latin America Recent Past, Current & Future Analysis for Critical Limb Ischemia Treatment by DFU Treatment - Wound Care Dressings, Biologics, Therapy Devices, Antibiotic Medications and Other DFU Treatments - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 201: Latin America Historic Review for Critical Limb Ischemia Treatment by DFU Treatment - Wound Care Dressings, Biologics, Therapy Devices, Antibiotic Medications and Other DFU Treatments Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 202: Latin America 15-Year Perspective for Critical Limb Ischemia Treatment by DFU Treatment - Percentage Breakdown of Value Sales for Wound Care Dressings, Biologics, Therapy Devices, Antibiotic Medications and Other DFU Treatments for the Years 2015, 2025 & 2030
    • TABLE 203: Latin America Recent Past, Current & Future Analysis for Critical Limb Ischemia Treatment by DFU Treatment End-Use - Ambulatory Surgery Centre End-Use, Other End-Uses and Hospital End-Use - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 204: Latin America Historic Review for Critical Limb Ischemia Treatment by DFU Treatment End-Use - Ambulatory Surgery Centre End-Use, Other End-Uses and Hospital End-Use Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 205: Latin America 15-Year Perspective for Critical Limb Ischemia Treatment by DFU Treatment End-Use - Percentage Breakdown of Value Sales for Ambulatory Surgery Centre End-Use, Other End-Uses and Hospital End-Use for the Years 2015, 2025 & 2030
    • TABLE 206: Latin America Recent Past, Current & Future Analysis for Critical Limb Ischemia Treatment by DFU Treatment Ulcer Type - Neuropathic Ulcers, Ischemic Ulcers and Neuro-ischemic Ulcers - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 207: Latin America Historic Review for Critical Limb Ischemia Treatment by DFU Treatment Ulcer Type - Neuropathic Ulcers, Ischemic Ulcers and Neuro-ischemic Ulcers Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 208: Latin America 15-Year Perspective for Critical Limb Ischemia Treatment by DFU Treatment Ulcer Type - Percentage Breakdown of Value Sales for Neuropathic Ulcers, Ischemic Ulcers and Neuro-ischemic Ulcers for the Years 2015, 2025 & 2030
  • ARGENTINA
    • TABLE 209: Argentina Recent Past, Current & Future Analysis for Critical Limb Ischemia Treatment by DFU Treatment - Wound Care Dressings, Biologics, Therapy Devices, Antibiotic Medications and Other DFU Treatments - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 210: Argentina Historic Review for Critical Limb Ischemia Treatment by DFU Treatment - Wound Care Dressings, Biologics, Therapy Devices, Antibiotic Medications and Other DFU Treatments Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 211: Argentina 15-Year Perspective for Critical Limb Ischemia Treatment by DFU Treatment - Percentage Breakdown of Value Sales for Wound Care Dressings, Biologics, Therapy Devices, Antibiotic Medications and Other DFU Treatments for the Years 2015, 2025 & 2030
    • TABLE 212: Argentina Recent Past, Current & Future Analysis for Critical Limb Ischemia Treatment by DFU Treatment End-Use - Ambulatory Surgery Centre End-Use, Other End-Uses and Hospital End-Use - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 213: Argentina Historic Review for Critical Limb Ischemia Treatment by DFU Treatment End-Use - Ambulatory Surgery Centre End-Use, Other End-Uses and Hospital End-Use Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 214: Argentina 15-Year Perspective for Critical Limb Ischemia Treatment by DFU Treatment End-Use - Percentage Breakdown of Value Sales for Ambulatory Surgery Centre End-Use, Other End-Uses and Hospital End-Use for the Years 2015, 2025 & 2030
    • TABLE 215: Argentina Recent Past, Current & Future Analysis for Critical Limb Ischemia Treatment by DFU Treatment Ulcer Type - Neuropathic Ulcers, Ischemic Ulcers and Neuro-ischemic Ulcers - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 216: Argentina Historic Review for Critical Limb Ischemia Treatment by DFU Treatment Ulcer Type - Neuropathic Ulcers, Ischemic Ulcers and Neuro-ischemic Ulcers Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 217: Argentina 15-Year Perspective for Critical Limb Ischemia Treatment by DFU Treatment Ulcer Type - Percentage Breakdown of Value Sales for Neuropathic Ulcers, Ischemic Ulcers and Neuro-ischemic Ulcers for the Years 2015, 2025 & 2030
  • BRAZIL
    • TABLE 218: Brazil Recent Past, Current & Future Analysis for Critical Limb Ischemia Treatment by DFU Treatment - Wound Care Dressings, Biologics, Therapy Devices, Antibiotic Medications and Other DFU Treatments - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 219: Brazil Historic Review for Critical Limb Ischemia Treatment by DFU Treatment - Wound Care Dressings, Biologics, Therapy Devices, Antibiotic Medications and Other DFU Treatments Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 220: Brazil 15-Year Perspective for Critical Limb Ischemia Treatment by DFU Treatment - Percentage Breakdown of Value Sales for Wound Care Dressings, Biologics, Therapy Devices, Antibiotic Medications and Other DFU Treatments for the Years 2015, 2025 & 2030
    • TABLE 221: Brazil Recent Past, Current & Future Analysis for Critical Limb Ischemia Treatment by DFU Treatment End-Use - Ambulatory Surgery Centre End-Use, Other End-Uses and Hospital End-Use - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 222: Brazil Historic Review for Critical Limb Ischemia Treatment by DFU Treatment End-Use - Ambulatory Surgery Centre End-Use, Other End-Uses and Hospital End-Use Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 223: Brazil 15-Year Perspective for Critical Limb Ischemia Treatment by DFU Treatment End-Use - Percentage Breakdown of Value Sales for Ambulatory Surgery Centre End-Use, Other End-Uses and Hospital End-Use for the Years 2015, 2025 & 2030
    • TABLE 224: Brazil Recent Past, Current & Future Analysis for Critical Limb Ischemia Treatment by DFU Treatment Ulcer Type - Neuropathic Ulcers, Ischemic Ulcers and Neuro-ischemic Ulcers - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 225: Brazil Historic Review for Critical Limb Ischemia Treatment by DFU Treatment Ulcer Type - Neuropathic Ulcers, Ischemic Ulcers and Neuro-ischemic Ulcers Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 226: Brazil 15-Year Perspective for Critical Limb Ischemia Treatment by DFU Treatment Ulcer Type - Percentage Breakdown of Value Sales for Neuropathic Ulcers, Ischemic Ulcers and Neuro-ischemic Ulcers for the Years 2015, 2025 & 2030
  • MEXICO
    • TABLE 227: Mexico Recent Past, Current & Future Analysis for Critical Limb Ischemia Treatment by DFU Treatment - Wound Care Dressings, Biologics, Therapy Devices, Antibiotic Medications and Other DFU Treatments - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 228: Mexico Historic Review for Critical Limb Ischemia Treatment by DFU Treatment - Wound Care Dressings, Biologics, Therapy Devices, Antibiotic Medications and Other DFU Treatments Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 229: Mexico 15-Year Perspective for Critical Limb Ischemia Treatment by DFU Treatment - Percentage Breakdown of Value Sales for Wound Care Dressings, Biologics, Therapy Devices, Antibiotic Medications and Other DFU Treatments for the Years 2015, 2025 & 2030
    • TABLE 230: Mexico Recent Past, Current & Future Analysis for Critical Limb Ischemia Treatment by DFU Treatment End-Use - Ambulatory Surgery Centre End-Use, Other End-Uses and Hospital End-Use - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 231: Mexico Historic Review for Critical Limb Ischemia Treatment by DFU Treatment End-Use - Ambulatory Surgery Centre End-Use, Other End-Uses and Hospital End-Use Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 232: Mexico 15-Year Perspective for Critical Limb Ischemia Treatment by DFU Treatment End-Use - Percentage Breakdown of Value Sales for Ambulatory Surgery Centre End-Use, Other End-Uses and Hospital End-Use for the Years 2015, 2025 & 2030
    • TABLE 233: Mexico Recent Past, Current & Future Analysis for Critical Limb Ischemia Treatment by DFU Treatment Ulcer Type - Neuropathic Ulcers, Ischemic Ulcers and Neuro-ischemic Ulcers - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 234: Mexico Historic Review for Critical Limb Ischemia Treatment by DFU Treatment Ulcer Type - Neuropathic Ulcers, Ischemic Ulcers and Neuro-ischemic Ulcers Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 235: Mexico 15-Year Perspective for Critical Limb Ischemia Treatment by DFU Treatment Ulcer Type - Percentage Breakdown of Value Sales for Neuropathic Ulcers, Ischemic Ulcers and Neuro-ischemic Ulcers for the Years 2015, 2025 & 2030
  • REST OF LATIN AMERICA
    • TABLE 236: Rest of Latin America Recent Past, Current & Future Analysis for Critical Limb Ischemia Treatment by DFU Treatment - Wound Care Dressings, Biologics, Therapy Devices, Antibiotic Medications and Other DFU Treatments - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 237: Rest of Latin America Historic Review for Critical Limb Ischemia Treatment by DFU Treatment - Wound Care Dressings, Biologics, Therapy Devices, Antibiotic Medications and Other DFU Treatments Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 238: Rest of Latin America 15-Year Perspective for Critical Limb Ischemia Treatment by DFU Treatment - Percentage Breakdown of Value Sales for Wound Care Dressings, Biologics, Therapy Devices, Antibiotic Medications and Other DFU Treatments for the Years 2015, 2025 & 2030
    • TABLE 239: Rest of Latin America Recent Past, Current & Future Analysis for Critical Limb Ischemia Treatment by DFU Treatment End-Use - Ambulatory Surgery Centre End-Use, Other End-Uses and Hospital End-Use - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 240: Rest of Latin America Historic Review for Critical Limb Ischemia Treatment by DFU Treatment End-Use - Ambulatory Surgery Centre End-Use, Other End-Uses and Hospital End-Use Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 241: Rest of Latin America 15-Year Perspective for Critical Limb Ischemia Treatment by DFU Treatment End-Use - Percentage Breakdown of Value Sales for Ambulatory Surgery Centre End-Use, Other End-Uses and Hospital End-Use for the Years 2015, 2025 & 2030
    • TABLE 242: Rest of Latin America Recent Past, Current & Future Analysis for Critical Limb Ischemia Treatment by DFU Treatment Ulcer Type - Neuropathic Ulcers, Ischemic Ulcers and Neuro-ischemic Ulcers - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 243: Rest of Latin America Historic Review for Critical Limb Ischemia Treatment by DFU Treatment Ulcer Type - Neuropathic Ulcers, Ischemic Ulcers and Neuro-ischemic Ulcers Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 244: Rest of Latin America 15-Year Perspective for Critical Limb Ischemia Treatment by DFU Treatment Ulcer Type - Percentage Breakdown of Value Sales for Neuropathic Ulcers, Ischemic Ulcers and Neuro-ischemic Ulcers for the Years 2015, 2025 & 2030
  • MIDDLE EAST
    • Critical Limb Ischemia Treatment Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Middle East for 2025 (E)
    • TABLE 245: Middle East Recent Past, Current & Future Analysis for Critical Limb Ischemia Treatment by Geographic Region - Iran, Israel, Saudi Arabia, UAE and Rest of Middle East Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
    • TABLE 246: Middle East Historic Review for Critical Limb Ischemia Treatment by Geographic Region - Iran, Israel, Saudi Arabia, UAE and Rest of Middle East Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 247: Middle East 15-Year Perspective for Critical Limb Ischemia Treatment by Geographic Region - Percentage Breakdown of Value Sales for Iran, Israel, Saudi Arabia, UAE and Rest of Middle East Markets for Years 2015, 2025 & 2030
    • TABLE 248: Middle East Recent Past, Current & Future Analysis for Critical Limb Ischemia Treatment by DFU Treatment - Wound Care Dressings, Biologics, Therapy Devices, Antibiotic Medications and Other DFU Treatments - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 249: Middle East Historic Review for Critical Limb Ischemia Treatment by DFU Treatment - Wound Care Dressings, Biologics, Therapy Devices, Antibiotic Medications and Other DFU Treatments Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 250: Middle East 15-Year Perspective for Critical Limb Ischemia Treatment by DFU Treatment - Percentage Breakdown of Value Sales for Wound Care Dressings, Biologics, Therapy Devices, Antibiotic Medications and Other DFU Treatments for the Years 2015, 2025 & 2030
    • TABLE 251: Middle East Recent Past, Current & Future Analysis for Critical Limb Ischemia Treatment by DFU Treatment End-Use - Ambulatory Surgery Centre End-Use, Other End-Uses and Hospital End-Use - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 252: Middle East Historic Review for Critical Limb Ischemia Treatment by DFU Treatment End-Use - Ambulatory Surgery Centre End-Use, Other End-Uses and Hospital End-Use Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 253: Middle East 15-Year Perspective for Critical Limb Ischemia Treatment by DFU Treatment End-Use - Percentage Breakdown of Value Sales for Ambulatory Surgery Centre End-Use, Other End-Uses and Hospital End-Use for the Years 2015, 2025 & 2030
    • TABLE 254: Middle East Recent Past, Current & Future Analysis for Critical Limb Ischemia Treatment by DFU Treatment Ulcer Type - Neuropathic Ulcers, Ischemic Ulcers and Neuro-ischemic Ulcers - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 255: Middle East Historic Review for Critical Limb Ischemia Treatment by DFU Treatment Ulcer Type - Neuropathic Ulcers, Ischemic Ulcers and Neuro-ischemic Ulcers Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 256: Middle East 15-Year Perspective for Critical Limb Ischemia Treatment by DFU Treatment Ulcer Type - Percentage Breakdown of Value Sales for Neuropathic Ulcers, Ischemic Ulcers and Neuro-ischemic Ulcers for the Years 2015, 2025 & 2030
  • IRAN
    • TABLE 257: Iran Recent Past, Current & Future Analysis for Critical Limb Ischemia Treatment by DFU Treatment - Wound Care Dressings, Biologics, Therapy Devices, Antibiotic Medications and Other DFU Treatments - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 258: Iran Historic Review for Critical Limb Ischemia Treatment by DFU Treatment - Wound Care Dressings, Biologics, Therapy Devices, Antibiotic Medications and Other DFU Treatments Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 259: Iran 15-Year Perspective for Critical Limb Ischemia Treatment by DFU Treatment - Percentage Breakdown of Value Sales for Wound Care Dressings, Biologics, Therapy Devices, Antibiotic Medications and Other DFU Treatments for the Years 2015, 2025 & 2030
    • TABLE 260: Iran Recent Past, Current & Future Analysis for Critical Limb Ischemia Treatment by DFU Treatment End-Use - Ambulatory Surgery Centre End-Use, Other End-Uses and Hospital End-Use - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 261: Iran Historic Review for Critical Limb Ischemia Treatment by DFU Treatment End-Use - Ambulatory Surgery Centre End-Use, Other End-Uses and Hospital End-Use Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 262: Iran 15-Year Perspective for Critical Limb Ischemia Treatment by DFU Treatment End-Use - Percentage Breakdown of Value Sales for Ambulatory Surgery Centre End-Use, Other End-Uses and Hospital End-Use for the Years 2015, 2025 & 2030
    • TABLE 263: Iran Recent Past, Current & Future Analysis for Critical Limb Ischemia Treatment by DFU Treatment Ulcer Type - Neuropathic Ulcers, Ischemic Ulcers and Neuro-ischemic Ulcers - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 264: Iran Historic Review for Critical Limb Ischemia Treatment by DFU Treatment Ulcer Type - Neuropathic Ulcers, Ischemic Ulcers and Neuro-ischemic Ulcers Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 265: Iran 15-Year Perspective for Critical Limb Ischemia Treatment by DFU Treatment Ulcer Type - Percentage Breakdown of Value Sales for Neuropathic Ulcers, Ischemic Ulcers and Neuro-ischemic Ulcers for the Years 2015, 2025 & 2030
  • ISRAEL
    • TABLE 266: Israel Recent Past, Current & Future Analysis for Critical Limb Ischemia Treatment by DFU Treatment - Wound Care Dressings, Biologics, Therapy Devices, Antibiotic Medications and Other DFU Treatments - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 267: Israel Historic Review for Critical Limb Ischemia Treatment by DFU Treatment - Wound Care Dressings, Biologics, Therapy Devices, Antibiotic Medications and Other DFU Treatments Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 268: Israel 15-Year Perspective for Critical Limb Ischemia Treatment by DFU Treatment - Percentage Breakdown of Value Sales for Wound Care Dressings, Biologics, Therapy Devices, Antibiotic Medications and Other DFU Treatments for the Years 2015, 2025 & 2030
    • TABLE 269: Israel Recent Past, Current & Future Analysis for Critical Limb Ischemia Treatment by DFU Treatment End-Use - Ambulatory Surgery Centre End-Use, Other End-Uses and Hospital End-Use - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 270: Israel Historic Review for Critical Limb Ischemia Treatment by DFU Treatment End-Use - Ambulatory Surgery Centre End-Use, Other End-Uses and Hospital End-Use Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 271: Israel 15-Year Perspective for Critical Limb Ischemia Treatment by DFU Treatment End-Use - Percentage Breakdown of Value Sales for Ambulatory Surgery Centre End-Use, Other End-Uses and Hospital End-Use for the Years 2015, 2025 & 2030
    • TABLE 272: Israel Recent Past, Current & Future Analysis for Critical Limb Ischemia Treatment by DFU Treatment Ulcer Type - Neuropathic Ulcers, Ischemic Ulcers and Neuro-ischemic Ulcers - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 273: Israel Historic Review for Critical Limb Ischemia Treatment by DFU Treatment Ulcer Type - Neuropathic Ulcers, Ischemic Ulcers and Neuro-ischemic Ulcers Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 274: Israel 15-Year Perspective for Critical Limb Ischemia Treatment by DFU Treatment Ulcer Type - Percentage Breakdown of Value Sales for Neuropathic Ulcers, Ischemic Ulcers and Neuro-ischemic Ulcers for the Years 2015, 2025 & 2030
  • SAUDI ARABIA
    • TABLE 275: Saudi Arabia Recent Past, Current & Future Analysis for Critical Limb Ischemia Treatment by DFU Treatment - Wound Care Dressings, Biologics, Therapy Devices, Antibiotic Medications and Other DFU Treatments - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 276: Saudi Arabia Historic Review for Critical Limb Ischemia Treatment by DFU Treatment - Wound Care Dressings, Biologics, Therapy Devices, Antibiotic Medications and Other DFU Treatments Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 277: Saudi Arabia 15-Year Perspective for Critical Limb Ischemia Treatment by DFU Treatment - Percentage Breakdown of Value Sales for Wound Care Dressings, Biologics, Therapy Devices, Antibiotic Medications and Other DFU Treatments for the Years 2015, 2025 & 2030
    • TABLE 278: Saudi Arabia Recent Past, Current & Future Analysis for Critical Limb Ischemia Treatment by DFU Treatment End-Use - Ambulatory Surgery Centre End-Use, Other End-Uses and Hospital End-Use - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 279: Saudi Arabia Historic Review for Critical Limb Ischemia Treatment by DFU Treatment End-Use - Ambulatory Surgery Centre End-Use, Other End-Uses and Hospital End-Use Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 280: Saudi Arabia 15-Year Perspective for Critical Limb Ischemia Treatment by DFU Treatment End-Use - Percentage Breakdown of Value Sales for Ambulatory Surgery Centre End-Use, Other End-Uses and Hospital End-Use for the Years 2015, 2025 & 2030
    • TABLE 281: Saudi Arabia Recent Past, Current & Future Analysis for Critical Limb Ischemia Treatment by DFU Treatment Ulcer Type - Neuropathic Ulcers, Ischemic Ulcers and Neuro-ischemic Ulcers - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 282: Saudi Arabia Historic Review for Critical Limb Ischemia Treatment by DFU Treatment Ulcer Type - Neuropathic Ulcers, Ischemic Ulcers and Neuro-ischemic Ulcers Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 283: Saudi Arabia 15-Year Perspective for Critical Limb Ischemia Treatment by DFU Treatment Ulcer Type - Percentage Breakdown of Value Sales for Neuropathic Ulcers, Ischemic Ulcers and Neuro-ischemic Ulcers for the Years 2015, 2025 & 2030
  • UNITED ARAB EMIRATES
    • TABLE 284: UAE Recent Past, Current & Future Analysis for Critical Limb Ischemia Treatment by DFU Treatment - Wound Care Dressings, Biologics, Therapy Devices, Antibiotic Medications and Other DFU Treatments - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 285: UAE Historic Review for Critical Limb Ischemia Treatment by DFU Treatment - Wound Care Dressings, Biologics, Therapy Devices, Antibiotic Medications and Other DFU Treatments Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 286: UAE 15-Year Perspective for Critical Limb Ischemia Treatment by DFU Treatment - Percentage Breakdown of Value Sales for Wound Care Dressings, Biologics, Therapy Devices, Antibiotic Medications and Other DFU Treatments for the Years 2015, 2025 & 2030
    • TABLE 287: UAE Recent Past, Current & Future Analysis for Critical Limb Ischemia Treatment by DFU Treatment End-Use - Ambulatory Surgery Centre End-Use, Other End-Uses and Hospital End-Use - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 288: UAE Historic Review for Critical Limb Ischemia Treatment by DFU Treatment End-Use - Ambulatory Surgery Centre End-Use, Other End-Uses and Hospital End-Use Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 289: UAE 15-Year Perspective for Critical Limb Ischemia Treatment by DFU Treatment End-Use - Percentage Breakdown of Value Sales for Ambulatory Surgery Centre End-Use, Other End-Uses and Hospital End-Use for the Years 2015, 2025 & 2030
    • TABLE 290: UAE Recent Past, Current & Future Analysis for Critical Limb Ischemia Treatment by DFU Treatment Ulcer Type - Neuropathic Ulcers, Ischemic Ulcers and Neuro-ischemic Ulcers - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 291: UAE Historic Review for Critical Limb Ischemia Treatment by DFU Treatment Ulcer Type - Neuropathic Ulcers, Ischemic Ulcers and Neuro-ischemic Ulcers Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 292: UAE 15-Year Perspective for Critical Limb Ischemia Treatment by DFU Treatment Ulcer Type - Percentage Breakdown of Value Sales for Neuropathic Ulcers, Ischemic Ulcers and Neuro-ischemic Ulcers for the Years 2015, 2025 & 2030
  • REST OF MIDDLE EAST
    • TABLE 293: Rest of Middle East Recent Past, Current & Future Analysis for Critical Limb Ischemia Treatment by DFU Treatment - Wound Care Dressings, Biologics, Therapy Devices, Antibiotic Medications and Other DFU Treatments - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 294: Rest of Middle East Historic Review for Critical Limb Ischemia Treatment by DFU Treatment - Wound Care Dressings, Biologics, Therapy Devices, Antibiotic Medications and Other DFU Treatments Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 295: Rest of Middle East 15-Year Perspective for Critical Limb Ischemia Treatment by DFU Treatment - Percentage Breakdown of Value Sales for Wound Care Dressings, Biologics, Therapy Devices, Antibiotic Medications and Other DFU Treatments for the Years 2015, 2025 & 2030
    • TABLE 296: Rest of Middle East Recent Past, Current & Future Analysis for Critical Limb Ischemia Treatment by DFU Treatment End-Use - Ambulatory Surgery Centre End-Use, Other End-Uses and Hospital End-Use - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 297: Rest of Middle East Historic Review for Critical Limb Ischemia Treatment by DFU Treatment End-Use - Ambulatory Surgery Centre End-Use, Other End-Uses and Hospital End-Use Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 298: Rest of Middle East 15-Year Perspective for Critical Limb Ischemia Treatment by DFU Treatment End-Use - Percentage Breakdown of Value Sales for Ambulatory Surgery Centre End-Use, Other End-Uses and Hospital End-Use for the Years 2015, 2025 & 2030
    • TABLE 299: Rest of Middle East Recent Past, Current & Future Analysis for Critical Limb Ischemia Treatment by DFU Treatment Ulcer Type - Neuropathic Ulcers, Ischemic Ulcers and Neuro-ischemic Ulcers - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 300: Rest of Middle East Historic Review for Critical Limb Ischemia Treatment by DFU Treatment Ulcer Type - Neuropathic Ulcers, Ischemic Ulcers and Neuro-ischemic Ulcers Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 301: Rest of Middle East 15-Year Perspective for Critical Limb Ischemia Treatment by DFU Treatment Ulcer Type - Percentage Breakdown of Value Sales for Neuropathic Ulcers, Ischemic Ulcers and Neuro-ischemic Ulcers for the Years 2015, 2025 & 2030
  • AFRICA
    • Critical Limb Ischemia Treatment Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Africa for 2025 (E)
    • TABLE 302: Africa Recent Past, Current & Future Analysis for Critical Limb Ischemia Treatment by DFU Treatment - Wound Care Dressings, Biologics, Therapy Devices, Antibiotic Medications and Other DFU Treatments - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 303: Africa Historic Review for Critical Limb Ischemia Treatment by DFU Treatment - Wound Care Dressings, Biologics, Therapy Devices, Antibiotic Medications and Other DFU Treatments Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 304: Africa 15-Year Perspective for Critical Limb Ischemia Treatment by DFU Treatment - Percentage Breakdown of Value Sales for Wound Care Dressings, Biologics, Therapy Devices, Antibiotic Medications and Other DFU Treatments for the Years 2015, 2025 & 2030
    • TABLE 305: Africa Recent Past, Current & Future Analysis for Critical Limb Ischemia Treatment by DFU Treatment End-Use - Ambulatory Surgery Centre End-Use, Other End-Uses and Hospital End-Use - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 306: Africa Historic Review for Critical Limb Ischemia Treatment by DFU Treatment End-Use - Ambulatory Surgery Centre End-Use, Other End-Uses and Hospital End-Use Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 307: Africa 15-Year Perspective for Critical Limb Ischemia Treatment by DFU Treatment End-Use - Percentage Breakdown of Value Sales for Ambulatory Surgery Centre End-Use, Other End-Uses and Hospital End-Use for the Years 2015, 2025 & 2030
    • TABLE 308: Africa Recent Past, Current & Future Analysis for Critical Limb Ischemia Treatment by DFU Treatment Ulcer Type - Neuropathic Ulcers, Ischemic Ulcers and Neuro-ischemic Ulcers - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 309: Africa Historic Review for Critical Limb Ischemia Treatment by DFU Treatment Ulcer Type - Neuropathic Ulcers, Ischemic Ulcers and Neuro-ischemic Ulcers Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 310: Africa 15-Year Perspective for Critical Limb Ischemia Treatment by DFU Treatment Ulcer Type - Percentage Breakdown of Value Sales for Neuropathic Ulcers, Ischemic Ulcers and Neuro-ischemic Ulcers for the Years 2015, 2025 & 2030

IV. COMPETITION

샘플 요청 목록
0 건의 상품을 선택 중
목록 보기
전체삭제